Malignant Glioma — Trials

Malignant Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,053 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 589
Recruiting: 314
Ph III recruiting: 16
Growth YoY: +38.9%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (324)

clinicaltrialsPublishedShowing 201–250 of 354 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04559230	Sacituzumab Govitecan in Recurrent Glioblastoma	recruiting	Phase 2	32	The University of Texas Health Science Center at San AntonioOTHER	1	Mar 30, 2026	clinicaltrials
NCT04655404	A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion	recruiting	Early Phase 1	15	Nationwide Children's HospitalOTHER	5	Mar 18, 2026	clinicaltrials